Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Visanne® (Dienogest 2mg) Regulatory Post Marketing Surveillance Study in Korea

NCT01788722 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT01788722
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01788722 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Visanne® (Dienogest 2mg) Regulatory Post Marketing Surveillance Study in Korea
Lead sponsor
Bayer
Phase
Observational
Overall status
Completed
Start date
July 19, 2013
Completion date
August 11, 2017
Enrollment
3,223 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endometriosis